Magnetically recoverable Fe3O4 nanocatalyst for the synthesis of biodynamically significant 1H-pyrazolo[1,2-b]phthalazine-5,10-diones derivatives and its DFT study

Ansari, Mohd Danish; Sagir, Hozeyfa; Yadav, Vikas; Yadav, Neetu; Verma, Ankit; Shakya, Sonam; Singh, Manjit; Siddiqui, I. R.

doi:10.1007/s11030-022-10532-3

Cited by 4 publications

(2 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In medicinal chemistry and drug discovery, VLCF enables the rapid synthesis of heterocyclic scaffolds with enhanced biological activity. [7][8][9][10][11] The technique has also found use in synthesis of advanced materials such as macromolecules, [12] polymers [13,14] and nanomaterials [15,16] for various applications. Furthermore, VLCF's selective activation of specific chemical bonds has opened new avenues for modifying natural products and developing functionalized molecules for industrial applications.…”

Section: Introductionmentioning

confidence: 99%

“…The applications of VLCF span various fields of chemistry. In medicinal chemistry and drug discovery, VLCF enables the rapid synthesis of heterocyclic scaffolds with enhanced biological activity [7–11] . The technique has also found use in synthesis of advanced materials such as macromolecules, [12] polymers [13,14] and nanomaterials [15,16] for various applications.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Visible Light‐Promoted Catalyst‐Free (VLCF) Scalable Synthesis of Novel Derivatives of Isoniazid and Maleimide

Iqbal,

Hussain,

Singh

et al. 2024

ChemistrySelect

View full text Add to dashboard Cite

We have developed a Visible Light Promoted Catalyst‐Free (VLCF) approach to synthesize novel conjugates of Isoniazid and Maleimide. This method involves the formation of an electron donor‐acceptor (EDA) complex between isoniazid and maleimide the photochemical activity of this complex drives the transformation. We successfully synthesized Isoniazid‐Maleimide derivatives (3a–d) at gram scale under visible light irradiation without an additional photo catalyst and without chromatographic purification resulting in excellent yields in a recyclable green solvent. Molecular docking was employed to predict the in silico anti‐tubercular activity and binding modes at the active site of enoyl‐ACP reductase, InhA. The newly synthesized compounds (3a–d) exhibited high binding affinity compared to Isoniazid and Isoniazid‐NAD adduct, indicating their potential for more effective anti‐tubercular activity. ADME analysis revealed favourable physicochemical properties, lipophilicity, water solubility, pharmacokinetics, and drug‐likeness for compound 3a, positioning it as a promising candidate for further drug discovery and development.

show abstract